Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome - PubMed (original) (raw)
. 1999 Dec 24;286(5449):2528-31.
doi: 10.1126/science.286.5449.2528.
J M Varley, T E Szydlo, D H Kang, D C Wahrer, K E Shannon, M Lubratovich, S J Verselis, K J Isselbacher, J F Fraumeni, J M Birch, F P Li, J E Garber, D A Haber
Affiliations
- PMID: 10617473
- DOI: 10.1126/science.286.5449.2528
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
D W Bell et al. Science. 1999.
Abstract
The hCHK2 gene encodes the human homolog of the yeast Cds1 and Rad53 G2 checkpoint kinases, whose activation in response to DNA damage prevents cellular entry into mitosis. Here, it is shown that heterozygous germ line mutations in hCHK2 occur in Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in the TP53 gene. These observations suggest that hCHK2 is a tumor suppressor gene conferring predisposition to sarcoma, breast cancer, and brain tumors, and they also provide a link between the central role of p53 inactivation in human cancer and the well-defined G2 checkpoint in yeast.
Comment in
- Checkpoint gene linked to human cancer.
Hagmann M. Hagmann M. Science. 1999 Dec 24;286(5449):2433-4. doi: 10.1126/science.286.5449.2433a. Science. 1999. PMID: 10636795 No abstract available.
Similar articles
- Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome.
Bougeard G, Limacher JM, Martin C, Charbonnier F, Killian A, Delattre O, Longy M, Jonveaux P, Fricker JP, Stoppa-Lyonnet D, Flaman JM, Frébourg T. Bougeard G, et al. J Med Genet. 2001 Apr;38(4):253-7. doi: 10.1136/jmg.38.4.253. J Med Genet. 2001. PMID: 11370630 Free PMC article. No abstract available. - Checkpoint gene linked to human cancer.
Hagmann M. Hagmann M. Science. 1999 Dec 24;286(5449):2433-4. doi: 10.1126/science.286.5449.2433a. Science. 1999. PMID: 10636795 No abstract available. - Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms.
Upton B, Chu Q, Li BD. Upton B, et al. Surg Oncol Clin N Am. 2009 Jan;18(1):145-56, ix. doi: 10.1016/j.soc.2008.08.006. Surg Oncol Clin N Am. 2009. PMID: 19056046 Review. - DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation.
Goi K, Takagi M, Iwata S, Delia D, Asada M, Donghi R, Tsunematsu Y, Nakazawa S, Yamamoto H, Yokota J, Tamura K, Saeki Y, Utsunomiya J, Takahashi T, Ueda R, Ishioka C, Eguchi M, Kamata N, Mizutani S. Goi K, et al. Cancer Res. 1997 May 15;57(10):1895-902. Cancer Res. 1997. PMID: 9157982 - TP53, hChk2, and the Li-Fraumeni syndrome.
Varley J. Varley J. Methods Mol Biol. 2003;222:117-29. doi: 10.1385/1-59259-328-3:117. Methods Mol Biol. 2003. PMID: 12710683 Review.
Cited by
- Implementation of a dyadic nomenclature for monogenic diseases.
Thaxton C, Biesecker LG, DiStefano M, Haendel M, Hamosh A, Owens E, Plon SE, Rehm HL, Berg JS. Thaxton C, et al. Am J Hum Genet. 2024 Sep 5;111(9):1810-1818. doi: 10.1016/j.ajhg.2024.07.019. Am J Hum Genet. 2024. PMID: 39241757 Review. - Oncogenes and tumor suppressor genes: functions and roles in cancers.
Dakal TC, Dhabhai B, Pant A, Moar K, Chaudhary K, Yadav V, Ranga V, Sharma NK, Kumar A, Maurya PK, Maciaczyk J, Schmidt-Wolf IGH, Sharma A. Dakal TC, et al. MedComm (2020). 2024 May 31;5(6):e582. doi: 10.1002/mco2.582. eCollection 2024 Jun. MedComm (2020). 2024. PMID: 38827026 Free PMC article. Review. - Previously reported CCDC26 risk variant and novel germline variants in GALNT13, AR, and MYO10 associated with familial glioma in Finland.
Nurminen R, Afyounian E, Paunu N, Katainen R, Isomäki M, Nurminen A, Scaravilli M, Tolppanen J, Fey V, Kivinen A, Helén P, Välimäki N, Kesseli J, Aaltonen LA, Haapasalo H, Nykter M, Rautajoki KJ. Nurminen R, et al. Sci Rep. 2024 May 21;14(1):11562. doi: 10.1038/s41598-024-62296-5. Sci Rep. 2024. PMID: 38773237 Free PMC article. - UK guidelines for the management of soft tissue sarcomas.
Hayes AJ, Nixon IF, Strauss DC, Seddon BM, Desai A, Benson C, Judson IR, Dangoor A. Hayes AJ, et al. Br J Cancer. 2024 May 11. doi: 10.1038/s41416-024-02674-y. Online ahead of print. Br J Cancer. 2024. PMID: 38734790 Review. - Case report: A germline CHEK1 c.613 + 2T>C leads to a splicing error in a family with multiple cancer patients.
Qian J, Peng M, Li Y, Liu W, Zou X, Chen H, Zhou S, Xiao S, Zhou J. Qian J, et al. Front Oncol. 2024 Apr 15;14:1380093. doi: 10.3389/fonc.2024.1380093. eCollection 2024. Front Oncol. 2024. PMID: 38686193 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous